AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study...
Increase the number of employees to guide the direction of the company and promote the growth strategy as a next-generation CDMO.
To continue its momentum...
Over 2,500m2 expansion for Adeno-Associated and Lentiviral Vector development and manufacturing built for large-scale and Late-Phase Clinical and Commercial Demands.
AGC Biologics, a leading global...
Eli Lilly and Company and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the...
Off-the-shelf workflow platform accelerates development of manufacturing processes for innovative biotherapeutics.
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced that Light...
